摘要 目的观察以壳聚糖(CS)材料为佐剂制备的德国小蠊变应原Bla g 7多肽纳米疫苗对小鼠过敏性气道炎症的疗效,探讨其免疫机制。方法用CS包裹Bla g 7多肽制成纳米疫苗;25只BALB/c小鼠用蟑螂粗提液致敏、激发,随机分为阴性对照组(A组)、模型组(B组)、Bla g 7多肽治疗组(C组)、Bla g 7多肽+CS治疗组(D组)、CS对照(E组)。通过HE染色观察小鼠肺部炎症;观察支气管肺泡灌洗液(BALF)中细胞总数和细胞分类;气道高反应仪监测治疗前后小鼠气道高反应性的变化。结果成功制备Bla g 7多肽纳米疫苗;D组与A组相比肺部病理改变不明显,BALF中的细胞总数、EOS计数均显著低于模型组(P<0.01),而C组和E组对致敏小鼠无明显疗效。气道高反应数值治疗前后变化差别有统计学意义(P<0.05)。结论Bla g 7多肽壳聚糖纳米疫苗对致敏小鼠具有免疫治疗作用,是一种新型的治疗蟑螂过敏性气道炎症的缓释制剂,为脱敏疫苗的研究提供了理论基础。
Abstract:To investigate the therapeutical effect of the chitosan(CS) nana-paritclessingle administration of Blag 7 polypeptide-CS nanoparticles used as a Bla g 7 polypeptide antigen in the sensitized mice and to explore its immune mechanism,the polypeptide Blag 7 was enclosed into CS to develop the Blag 7 polypeptide entrapped CS nano-particles.In the present experiment,25 BALB/c mice were divided randomly into the Blag 7 polypeptide treated group(group A,n= 5),Blag 7 polypeptide plus CS treated group(group B,n= 5),CS=control group(group C,n= 5),model group(group D,n= 5) and negative control group(group E,n= 5),After sensitization by intraperitoneal route and challenged by intranasal instillation with crude extracts of German cockroach,the inflammatory changes in the mouse lung tissues were observed after the lung tissues were fixed and stained with haematoxylin and eosin(H&E).The total cell number and the cellular composition of bronchoalveolar lavage fluid(BALF) were detected;and the changes of the mouse airway hyper-reactivity were determined by the whole body plethysmograohy pre-and post-treatments.In these ways,the Bla g 7 peptide CS nano-particel vaccine was successfully developed.It was found that the pathological changes in mouse lungs in group D were not so prominent in comparison with those of group A of mice sensitized with crude extract of German cockroach.in which the development of eosinophil infiltration in the airway of mice in D group could be demonstrated.The lung inflammatory reactions and the mucus secretion in lungs of D group were significantly alleviated than those of the B group.but there was no therapeutical effect for the mice fed with the isodoses of Blag 7 polypeptide or CS.It was also shown that the airway hyper-reactivity of mice was depressed after treatment(P<0.05).It is evident that CS nano-particles show definite therapeutical effect and may serve as a powerful vehicle to improve the tolerance effect of the Blag 7 polypeptide-CS nanoparticle vaccine,and a single administration of Blag 7 polypeptide-CS nanoparticle vaccine may hold promise as a new strategy to desensitize the Blag 7 sensitized disease.
[1]Bernton HS,Brown H.Insect allerey-preli minary studies of thecockroach〔J〕.Allergy,1964:35:506-132.
[2]Chapman MD,Vailes LD,Hayden ML.Cockroach allergens andtheir role in asthma in kay AB editor allergy and allergic disease〔J〕.Blackweil Science Ltd,1996,942-951.
[3]Jeong KY,Lee J,Lee IY,et al.Allergenicity of recombinantBla g 7,German cockroachtropomyosin〔J〕.Allergy(Copenhag-en),2003,58(10):1059-1063.
[4]许卓谦,刘志刚.泼尼松对蟑螂致敏小鼠支气管哮喘模型的作用〔J〕.中华结核和呼吸杂志,2006,29(4):282-284.
[5]MahlerV,VrtalaS,KussO,et al.Vaccines for birchpollen allergbased on genetically engineer edhypo allergenic derivatives of the-majo birchpollen allergen,Bet v 1〔J〕.Clin Exp Allergy,2004,34(1):115-122.
[6]Calvo P,Remunan-Lopez C,Vila-Jato JL,et al.Novel hydro-philic chitosan-polyethylene oxide nanoparticles as protein carri-ers〔J〕.J Appl P oly S ci,1997,63(1)∶25.
[7]Ki mJ,Mckinley L,Siddiqui J,et al.Prevention and reversal ofpul monary inflammation and airway hyperresponsiveness by dex-amethasone treat ment in a murine model of asthma induced byhouse dust〔J〕.AmJ Physiol Lung Cell Mol Physiol,2004,287:503-509.
[8]Ki m J,Merry AC,Nemzek JA,et al.Eotaxin represents theprincipal eosinophil chemoattractant in a novel murine asthmamodel induced by house dust containing cockroach allergens〔J〕.JImmunol,2001,167:2808-2815.
[9]Unerwood S,Fostere M,Raeburn D,et al.Ti me-course of anti-gen-induced airway inflammation in the Guinea pig and its rela-tionship to airway hyperresponsiveness〔J〕.Eur Respir J,1995,8:2104-2113.
[10]Corsi K,Chellat F,Yah ia L.Fernandes JC.Mesenchy2 malstemcells,M G63 and HEK293 t ransfect ion using chitosan-DNAnanopart icles〔J〕.Biomaterials,2003,24(7):1255.
[11]van der L ubben I M,Verhoef JC,Bo rchard G,et al.Chi2 tosan fo r muco sal vaccinat ion〔J〕.Adv Drug Deliv Rev,2001,52(2):139.
[12]喻海琼,刘志刚,于琨瑛等.重组屋尘螨2类变应原疫苗免疫治疗小鼠过敏性气道炎症的研究〔J〕.中国寄生虫学与寄生虫病杂志,2006,24(06):414-420.